The pharmaceutical sector increasingly relies on both large supply and custom creation of key ingredients. Large supply caters to standard substance needs with predictable quality and attractive pricing, suitable for established manufacturing methods. However, the drive for innovative therapeutic molecules often necessitates tailored creation, wher